Physical activity measured by accelerometry in paediatric and young adult patients with inflammatory bowel disease

Ken Lund1,2,3, Michael Due Larsen4,5, Torben Knudsen6,7

  • 1Center for Clinical Epidemiology, Odense University Hospital, Kloevervaenget 30, Entrance 216, 5000, Odense, Denmark. ken.lund@rsyd.dk.

Insights

Young patients with inflammatory bowel disease (IBD) show moderate physical activity levels. Activity volume was higher in males and decreased with age, with no significant difference between ulcerative colitis (UC) and Crohn

Area of Science:

  • Pediatric gastroenterology
  • Clinical research
  • Biomedical engineering

Background:

  • Physical activity is crucial for the health of pediatric and young adult patients with inflammatory bowel disease (IBD).
  • Objective measurement of physical activity in this population has been limited.
  • Understanding activity levels can inform management strategies for IBD patients.

Purpose of the Study:

  • To objectively measure and describe physical activity levels in pediatric and young adult patients with IBD using accelerometry.
  • To compare physical activity levels between patients with ulcerative colitis (UC) and Crohn's disease (CD).

Main Methods:

  • Recruited 61 Danish IBD patients aged 10-20 years in clinical remission (faecal calprotectin < 200 µg/mg).
  • Assessed physical activity using tri-axial wrist accelerometry over seven days.
  • Quantified activity using the Euclidean Norm Minus One (ENMO) metric (mg) and time spent in Moderate-to-Vigorous Physical Activity (MVPA).

Main Results:

  • The average daily activity volume (ENMO) was 31.5 mg.
  • Patients spent an average of 32 minutes per day in MVPA.
  • No significant difference in activity volume was found between UC and CD patients. Males and younger patients (10-13 years) exhibited higher activity levels compared to females and older patients (18-20 years).

Conclusions:

  • Tri-axial accelerometry provides objective data on physical activity in young IBD patients in remission.
  • Physical activity levels did not differ significantly between UC and CD patients.
  • Activity volume was higher in males and inversely associated with age.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
402
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
433
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
348
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
205